Sabine Schuster
Freiburg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Frequent high-level rifaximin resistance in Escherichia coli associated with long-term treatment of patients with liver cirrhosis: a prospective, controlled study.
Journal: Microbiology spectrum
Published: October 13, 2025
Comparative reassessment of AcrB efflux inhibitors reveals differential impact of specific pump mutations on the activity of potent compounds.
Journal: Microbiology spectrum
Published: January 03, 2024
A Screening of Antimalarials Extends the Range of Known Escherichia coli AcrB Efflux Substrates and Reveals Two Candidates with Antimicrobial Drug-Enhancing Activity.
Journal: Microbial drug resistance (Larchmont, N.Y.)
Published: October 18, 2022
Exploring the Contribution of the AcrB Homolog MdtF to Drug Resistance and Dye Efflux in a Multidrug Resistant E. coli Isolate.
Journal: Antibiotics (Basel, Switzerland)
Published: April 07, 2021
New Topoisomerase Inhibitors: Evaluating the Potency of Gepotidacin and Zoliflodacin in Fluoroquinolone-Resistant Escherichia coli upon tolC Inactivation and Differentiating Their Efflux Pump Substrate Nature.
Journal: Antimicrobial agents and chemotherapy
Published: September 07, 2020
Limited Multidrug Resistance Efflux Pump Overexpression among Multidrug-Resistant Escherichia coli Strains of ST131.
Journal: Antimicrobial agents and chemotherapy
Published: August 13, 2020
Detection of High-Level Rifaximin Resistance in Enteric Bacteria by Agar Screen.
Journal: Microbial drug resistance (Larchmont, N.Y.)
Published: December 20, 2019
Efflux-Mediated Resistance to New Oxazolidinones and Pleuromutilin Derivatives in Escherichia coli with Class Specificities in the Resistance-Nodulation-Cell Division-Type Drug Transport Pathways.
Journal: Antimicrobial agents and chemotherapy
Published: May 21, 2019
Proof of an Outer Membrane Target of the Efflux Inhibitor Phe-Arg-β-Naphthylamide from Random Mutagenesis.
Journal: Molecules (Basel, Switzerland)
Published: January 10, 2019
Contribution of AcrAB-TolC to multidrug resistance in an Escherichia coli sequence type 131 isolate.
Contribution of AcrAB-TolC to multidrug resistance in an Escherichia coli sequence type 131 isolate.
Journal: International journal of antimicrobial agents
Published: December 06, 2016
How are Pediatric Hospitals in North-Rhine Westfalia Prepared to Overcome Language Barriers? A Pilot Study Exploring The Structural Quality of Inpatient Care
Journal: Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))
Published: May 05, 2016
Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB.
Journal: Antimicrobial agents and chemotherapy
Published: February 10, 2016
Last Updated: 09/26/2026